With independent studies showing that 8 out of 10 people use their inhalers incorrectly1, inhaler technique training supports more accurate drug delivery, helping patients get the full benefit of their medication, and resulting in better disease management.

The Vitalograph AIM (Aerosol Inhalation Monitor) is designed to assist medical practitioners in training patients to use their inhalers correctly.

The AIM validates good technique in the use of both DPI and MDI inhalers. Using a hygienic, single-use disposable inhaler simulator, the AIM is the only interactive device that gives instant visual feedback on the following critical elements of inhaler technique:

  • Inspiratory acceleration at start of inspiration
  • Timing of firing of MDI
  • Inspiratory flow rate throughout inspiration
  • Inhalation time within target flow range
  • Breath-hold time at end of inhalation

The Global Initiative for Asthma (GINA) acknowledges that inhalers should be prescribed only after patients have been trained to use them properly.2 In addition, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) states that it is essential to ensure that inhaler technique is correct and to re-check this at each visit and for each change of inhaler device.3

Reimbursement is available for demonstration, training, or evaluation of patient utilization of an inhaler. Which means that the AIM could bring you more than $16.96 for every patient using an inhaler with CPT code 94664.

Vitalograph is launching the AIM with an introductory offer of a 30-Day Money Back guarantee and a FREE starter pack worth $27 with every device.

Speaking about the AIM, Stephen Foster, Respiratory and Allergy Specialist Pharmacist, says: “The AIM is a really useful means of training patients to use their inhalers properly and should be an essential part of a respiratory clinician’s kit in the future if we are to improve compliance and concordance in our patients.”


References

1 d’Ancona, G., & Weinman, J. (2021). Improving adherence in chronic airways disease: are we doing it wrongly? Breathe (Sheffield, England), 17(2), 210022. https://doi.org/10.1183/20734735.0022

2. The 2021 Update of the Global Strategy For Asthma Management and Prevention (www.ginasthma.org)

3. The 2021 Report – Global Strategy for the Diagnosis, Management, and Prevention of COPD (www.goldcopd.org)